United States · FDA National Drug Code directory
lurasidone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-211_8f42d8c8-cccf-49e3-9bad-e9a45d8d7896
- Product NDC
- 72205-211
- Form
- TABLET, FILM COATED
- Composition / generic term
- lurasidone hydrochloride
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230209
- Source listing expiry
- 20261231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (72205-211-05) · 72205-211-05
- 30 TABLET, FILM COATED in 1 BOTTLE (72205-211-30) · 72205-211-30
- 90 TABLET, FILM COATED in 1 BOTTLE (72205-211-90) · 72205-211-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →